David H. Ilson, MD, PhD, explains why radiotherapy should be included as part of adjuvant therapy for gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
David H. Ilson, MD, PhD, explains why radiotherapy should be included as part of adjuvant therapy for gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
Ramucirumab improves survival for patients with advanced HCC and elevated AFP regardless of prior TACE treatment, according to a post-hoc analysis of REACH/REACH-2.
Ramucirumab improves survival for patients with advanced HCC and elevated AFP regardless of prior TACE treatment, according to a post-hoc analysis of REACH/REACH-2.